Literature DB >> 21292561

Preoperative grading scale to predict survival in patients undergoing resection of malignant primary osseous spinal neoplasms.

Matthew J McGirt1, Ziya L Gokaslan, Kaisorn L Chaichana.   

Abstract

BACKGROUND CONTEXT: Large population-based studies of malignant primary osseous spinal neoplasms are lacking and are necessary to have sufficient statistical power to determine if various patient-related factors are in fact significant indicators of prognosis.
PURPOSE: Using a 30-year US national cancer registry (Surveillance, Epidemiology, and End Results [SEER]), we introduce a preoperative grading scale that is associated with survival in patients undergoing surgical resection for malignant primary osseous spinal neoplasms. STUDY
DESIGN: Large-scale retrospective study. PATIENT SAMPLE: SEER registry. OUTCOME MEASURE: Survival.
METHODS: The SEER registry (1973-2003) was queried to identify adult patients undergoing surgical resection of histologically confirmed primary spinal chordoma, chondrosarcoma, or osteosarcoma via International Classification of Disease for Oncology, Third Edition coding. Variables independently associated with survival were determined via Cox proportional hazards regression analysis for all tumor types. A grading scale comprising these independent survival predictors was then developed and applied to each histology-specific tumor cohort.
RESULTS: Three hundred forty-two patients who underwent surgical resection of a malignant primary osseous spinal neoplasm (114 chordoma, 156 chondrosarcoma, and 72 osteosarcoma) were identified. Overall median survival after surgical resection was histology specific (osteosarcoma: 22 months; chordoma: 100 months; and chondrosarcoma: 160 months). Increasing age (years) and increasing tumor invasion (confined to periosteum; invasion through periosteum into adjacent tissues; and distal site metastasis) were the only variables independently associated with decreased survival (p<.05) for all tumor types. For spinal chordoma, sacrum/pelvic location (p<.05) and earlier year of surgery (p<.005) were also independently associated with decreased survival. Using variables of patient age, extent of local tumor invasion, and metastasis status in a five-point grading scale, increasing score (1-5) closely correlated (p<.001) with decreased survival for chordoma, chondrosarcoma, and osteosarcoma.
CONCLUSIONS: In our analysis of a US population-based cancer registry (SEER), a grading scale consisting of age, metastasis status, and extent of local tumor invasion was associated with overall survival after surgical resection of chordoma, chondrosarcoma, and osteosarcoma of the spine. Although this analysis could not take into account specific chemotherapy regimens and variations in surgical technique, this grading scale may offer valuable prognostic data based on variables available to the surgeon and patient before surgery and may help guide level of aggressiveness in subsequent treatment strategies.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21292561     DOI: 10.1016/j.spinee.2011.01.013

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  12 in total

1.  Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine.

Authors:  Armin Arshi; Justin Sharim; Don Y Park; Howard Y Park; Hamed Yazdanshenas; Nicholas M Bernthal; Arya N Shamie
Journal:  Spine J       Date:  2016-11-14       Impact factor: 4.166

2.  Surgical treatment of sacral chordoma: prognostic variables for local recurrence and overall survival.

Authors:  Péter Pál Varga; Zsolt Szövérfi; Charles G Fisher; Stefano Boriani; Ziya L Gokaslan; Mark B Dekutoski; Dean Chou; Nasir A Quraishi; Jeremy J Reynolds; Alessandro Luzzati; Richard Williams; Michael G Fehlings; Niccole M Germscheid; Aron Lazary; Laurence D Rhines
Journal:  Eur Spine J       Date:  2014-12-23       Impact factor: 3.134

Review 3.  The value of extent of resection of glioblastomas: clinical evidence and current approach.

Authors:  Joao Paulo Almeida; Kaisorn L Chaichana; Jordina Rincon-Torroella; Alfredo Quinones-Hinojosa
Journal:  Curr Neurol Neurosci Rep       Date:  2015       Impact factor: 5.081

4.  Sacral chordoma: do the width of surgical margin and the use of photon/proton radiotherapy affect local disease control?

Authors:  Tomohiro Fujiwara; Yusuke Tsuda; Jonathan Stevenson; Michael Parry; Lee Jeys
Journal:  Int Orthop       Date:  2019-12-20       Impact factor: 3.075

5.  Chordoma: a systematic review of the epidemiology and clinical prognostic factors predicting progression-free and overall survival.

Authors:  S H Bakker; W C H Jacobs; W Pondaag; H Gelderblom; R A Nout; P D S Dijkstra; W C Peul; C L A Vleggeert-Lankamp
Journal:  Eur Spine J       Date:  2018-09-15       Impact factor: 3.134

6.  Survival and recurrence rate after treatment for primary spinal sarcomas.

Authors:  Wonik Cho; Ung-Kyu Chang
Journal:  J Korean Neurosurg Soc       Date:  2013-04-30

7.  Analysis of prognostic factors for survival in patients with primary spinal chordoma using the SEER Registry from 1973 to 2014.

Authors:  Yue Pan; Lingyun Lu; Junquan Chen; Yong Zhong; Zhehao Dai
Journal:  J Orthop Surg Res       Date:  2018-04-06       Impact factor: 2.359

8.  [An application of posterior cervical and transoral approaches to treating primary malignant osseous tumors in craniovertebral junction].

Authors:  Yu Zhang; Fuzhi Ai; Suochao Fu; Keke Li; Hong Xia; Zenghui Wu; Xiangyang Ma
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-09-15

9.  C-reactive protein as a prognostic factor in patients with chordoma of lumbar spine and sacrum--a single center pilot study.

Authors:  Gerhard Martin Hobusch; Florian Bodner; Sonja Walzer; Rodrig Marculescu; Philipp T Funovics; Irene Sulzbacher; Reinhard Windhager; Joannis Panotopoulos
Journal:  World J Surg Oncol       Date:  2016-04-18       Impact factor: 2.754

10.  Outcomes of Surgery for Sacral Chordoma and Impact of Complications: A Report of 50 Consecutive Patients With Long-Term Follow-Up.

Authors:  Scott L Zuckerman; Sun-Ho Lee; George J Chang; Garrett L Walsh; Reza J Mehran; Ziya L Gokaslan; Ganesh Rao; Claudio E Tatsui; Laurence D Rhines
Journal:  Global Spine J       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.